Advertisement
Screener

McKESSON CORPORATION (MCK) Overview

McKESSON CORPORATION (MCK) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 5.15; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual 9.59; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 8.92; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 6.25; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$688.91$758.42$834.95$919.20$1,011.95$1,114.062025-11-062026-11-06$204.64$287.19$403.05$565.64$793.83$1,114.062021-11-082026-11-06$102.82$165.93$267.79$432.18$697.47$1,125.622016-11-072026-11-06$32.18$66.31$136.67$281.67$580.51$1,196.412009-01-022026-11-06$32.18$66.31$136.67$281.67$580.51$1,196.412009-01-022026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.06K
Previous close
$864.82
Change
$196.19
Change (%)
22.69%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

MCK
+5.75%
S&P 500
(m)

1 year

MCK
+13.97%
S&P 500
(m)

3 years

MCK
+101.53%
S&P 500
(m)

5 years

MCK
+331.93%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 5.15

5.076.257.428.599.7731 Dec 2024: estimate (m); actual 6.9531 Dec 2024(m)30 Jun 2025: estimate (m); actual 6.2530 Jun 2025(m)30 Sept 2025: estimate (m); actual 8.9230 Sept 2025(m)31 Dec 2025: estimate (m); actual 9.5931 Dec 2025(m)30 Jun 2026: estimate (m); actual 5.1530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)5.15(m)(m)
1 Oct 202531 Dec 2025(m)9.59(m)(m)
1 Jul 202530 Sept 2025(m)8.92(m)(m)
1 Apr 202530 Jun 2025(m)6.25(m)(m)
1 Oct 202431 Dec 2024(m)6.95(m)(m)

31 Mar 2026 ○ Estimate (m) ● Actual 38.38

7.1515.0022.8630.7138.5631 Mar 2022: estimate (m); actual 7.2331 Mar 2022(m)31 Mar 2023: estimate (m); actual 25.0331 Mar 2023(m)31 Mar 2024: estimate (m); actual 22.3931 Mar 2024(m)31 Mar 2025: estimate (m); actual 25.7231 Mar 2025(m)31 Mar 2026: estimate (m); actual 38.3831 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202531 Mar 2026(m)38.38(m)(m)
1 Apr 202431 Mar 2025(m)25.72(m)(m)
1 Apr 202331 Mar 2024(m)22.39(m)(m)
1 Apr 202231 Mar 2023(m)25.03(m)(m)
1 Apr 202131 Mar 2022(m)7.23(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 105.38B ■ Earnings 0.61B — Profit margin 0.58%

-12.74B-0.4%31.14B0.6%75.02B1.7%118.90B2.7%30 Sept 2025: revenue 103.15B; earnings 1.11B; profit margin 1.08%30 Sept 202531 Dec 2025: revenue 106.16B; earnings 1.19B; profit margin 1.12%31 Dec 202531 Mar 2026: revenue 96.30B*; earnings 1.68B*; profit margin 1.75%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-01-01 to 2026-03-31; USD.31 Mar 202630 Jun 2026: revenue 105.38B; earnings 0.61B; profit margin 0.58%30 Jun 2026

31 Mar 2026 ■ Revenue 403.43B ■ Earnings 4.76B — Profit margin 1.18%

-48.41B-0.1%118.34B0.7%285.09B1.5%451.84B2.3%31 Mar 2023: revenue 276.71B; earnings 3.56B; profit margin 1.29%31 Mar 202331 Mar 2024: revenue 308.95B; earnings 3.00B; profit margin 0.97%31 Mar 202431 Mar 2025: revenue 359.05B; earnings 3.29B; profit margin 0.92%31 Mar 202531 Mar 2026: revenue 403.43B; earnings 4.76B; profit margin 1.18%31 Mar 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.06K(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.06KHigh(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning MCK

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
45.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
869.00K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-2.96%*
Total return · month
-3.10%*
Total return · quarter
15.81%*
Total return · half year
0.76%*
Total return · year to date
5.75%*
Total return · 1 year
13.97%*
Total return · 3 years
101.53%*
Total return · 5 years
331.93%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

McKESSON CORPORATION Overview

View more →

(m)

(m)

SEC CIK
927653
Industry (SIC)
5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
Country of operation
United States
Business address
6555 STATE HIGHWAY 161, IRVING, Texas, 75039, United States
Fiscal year end
0331
Phone
972-446-4800

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cencora, Inc. (COR)United States$59.130B20.57
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B